WHO Maintains Mpox Alert Amid Surge in West Africa
The WHO has extended the mpox global health emergency as cases surge in West Africa and beyond, highlighting ongoing international health challenges. Learn more about the current situation and response efforts.
The World Health Organization (WHO) has reaffirmed the ongoing status of mpox as a global health emergency, citing a continued rise in cases worldwide. Since the outbreak began in early 2024, with initial reports from the Democratic Republic of Congo, over 37,000 confirmed cases have been documented across 25 countries, resulting in approximately 125 fatalities.
The WHO director general, Tedros Adhanom Ghebreyesus, announced the extension of the emergency declaration after a meeting with international experts. While some regions have shown progress in controlling the spread, there has been a notable surge in cases in West Africa, alongside virus transmission outside Africa. The Democratic Republic of Congo remains the most affected, accounting for 60% of confirmed cases and 40% of deaths related to mpox.
Other countries like Uganda, Burundi, and Sierra Leone have also experienced significant outbreaks, with Sierra Leone reporting an increase in cases this year. The virus causes symptoms including rash, severe flu-like symptoms, and in some instances, severe complications. It was first classified as an international emergency by WHO in August 2024.
The decision to maintain the emergency status was based on the rising number of cases and the likelihood of undetected transmissions beyond Africa. Challenges such as inadequate monitoring, limited funding for treatment, and insufficient international support continue to hinder containment efforts. The WHO emphasizes the importance of sustained global collaboration and resource allocation to combat the ongoing mpox threat.
source: https://medicalxpress.com/news/2025-06-mpox-west-africa-surge.html
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Breakthrough in HIV Vaccine Research Identifies Potent New Antibody Target
Scientists have made a significant breakthrough in HIV vaccine development by identifying a new antibody target capable of neutralizing diverse HIV strains. This advance could pave the way for more effective vaccines against the virus, with early human trials already underway.
Innovative Mobile App Enhances Drug Safety Reporting in Uganda, Study Shows
A large-scale trial in Uganda shows that the Med Safety mobile app increases adverse drug reaction reporting by healthcare workers, strengthening pharmacovigilance and improving patient safety in LMICs.
Urgent Call for Reform in the Treatment of Incarcerated Mothers and Their Babies
A new report calls for urgent reforms in England and Wales' criminal justice system to address the emotional trauma caused by separating incarcerated mothers from their babies. The study highlights systemic failures and advocates for community-based alternatives, trauma-informed care, and better support for both mothers and staff.
Innovative 3D Bioprinted Brain Model Advances Understanding of Neurological Disorders
Researchers have developed a 3D bioprinted brain model that closely mimics human neural architecture, offering new insights into neurodegenerative diseases and alcohol-induced neurotoxicity.